Reduction of numbers of animals used in the quality control of biologicals

Alternatives to Laboratory Animals

Volumn 32, Issue SUPPL. 2, 2004, Pages 53-58

  Hendriksen, Coenraad F M ^a  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Potency testing; Quality control; Reduction; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INACTIVATED VACCINE; TOXOID; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING REDUCTION; ANIMAL TESTING REPLACEMENT; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; DRUG POTENCY; DRUG QUALITY; DRUG RESEARCH; FEASIBILITY STUDY; IMMUNE RESPONSE; INFORMATION PROCESSING; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; SEROLOGY;

ANIMALIA;

EID: 8744239567     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403202s11     Document Type: Conference Paper

References (15)

1. van der Gun, J.W., Borsboom, D., Jooren, J., van den Maagdenberg, B., & Hendriksen, C.F.M. (1999). The use of Vero cell for the determination of residual specific toxicity of batches of diphtheria toxoid. Developments in Biological Standards 101, 319.
2. Leenaars, P.P.A.M., Kersten, G.F.A., de Bruijn, M.L.H. & Hendriksen, C.F.M. (2001). An in vitro approach in quality control of toxoid vaccines. Vaccine 19, 2729-2733.
3. Cussler, K., Morton, D.B. & Hendriksen, C.F.M. (1999). Humane endpoints in vaccine research and quality control. In Humane Endpoints in Animal Experiments for Biomedical Research (ed. C.F.M. Hendriksen & D.B. Morton), pp. 95-101. London, UK: The Royal Society of Medicine Press.
4. Prigge, R. (1937). Experimentelle untersuchungen über die wirksamkeit von diphtherie impfstoffen (Experimental investigations of the activity of diphtheria vaccines). Deutsche Medizinische Wochenschrift 39, 1478-1482.
5. Hendriksen, C.F.M., van der Gun, J.W., Marsman, F.R. & Kreeftenberg, J.G. (1987). The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European Pharmacopoeia. Journal of Biological Standards 15, 353-362.
6. Hendriksen, C.F., Slob, W., van der Gun, J.W., Westendorp, J.H., den Bieman, M., Hesp, A. & van Zutphen, L.F. (1994). Immunogenicity testing of diphtheria and tetanus vaccines by using isogenic mice with possible implications for potency testing. Laboratory Animals 28, 121-129.
7. Kreeftenberg, J.G., van der Gun, J., Marsman, F.R., van Asten, J.A.A.M., Sekhuis, V.M. & Hendriksen, C.F.M. (1985). An investigation of a mouse model to estimate the potency of the diphtheria component in vaccines. Journal of Biological Standards 13, 229-234.
8. Hendriksen, C.F.M., van der Gun, J.W., Nagel, J. & Kreeftenberg, J.G. (1988). The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. Journal of Biological Standards 16, 287-297.
9. Hendriksen, C.F.M., van der Gun, J.W. & Kreeftenberg, J.G. (1989). Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro toxin binding inhibition (ToBI) test. Journal of Biological Standards 17, 191-200.
10. van de Ark, A., van Straaten-van de Kapelle, I., Akkermans, A., Hendriksen, C. & van de Donk, H. (1994). Development of pertussis serological potency test: serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model. Biologicals 22, 233-242.
11. Akkermans, A.M., Marsman, F.M., Hendriksen, C.F.M., de Jong, W.H. & van de Donk, H.J.M. (1993). Evaluation and Validation of a Single-dilution Potency Assay Based upon Serology of Vaccines containing Diphtheria Toxoid, 22pp. RIVM Annual Scientific Report No. 172203001. Bilthoven, The Netherlands: RIVM.
12. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen.
13. Metz, B., Hendriksen, C., Jiskoot, W. & Kersten, G.F. (2002). Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20, 2411-2430.
14. Hendriksen, C.F.M., Woltjes, J., Akkermans, A.M., van der Gun, J.W., Marsman, F.R., Verschure, M.H. & Veldman, K. (1994). Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Biologicals 22, 257-268.
15. Winsnes, R. & Hendriksen, C.F.M. (2001). Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use: summary of all three phases. Pharmeuropa, Special Issue, BIO 2001-2, 75-77.